Akèy › Kansè pwostat › Georgia
Etid klinik pou Kansè pwostat nan Georgia
42 etid pou Kansè pwostat ap chèche patisipan nan sit nan Georgia.
Vil nan Georgia
Tèks ofisyèl etid la (Anglè)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Northside Hospital, Atlanta
- Northside Hospital - Duluth, Duluth
- Northside Hospital - Gwinnett, Lawrenceville
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT06931340Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- CTCA at Southeastern Regional Medical Center, Newnan
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT07200830A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Emory University, Atlanta
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06465069Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Northeast Georgia Medical Center Braselton, Braselton
- Atlanta VA Medical Center, Decatur
- Northeast Georgia Medical Center-Gainesville, Gainesville
- ak 4 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069Addressing Health Literacy With a Tailored Survivorship Care Plan
- Grady Memorial Hospital, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Atlanta VA Medical Center, Atlanta
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 30, 2026 · NCT06674863Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
- Emory University, Atlanta
Ap rekriteFaz 4
Laj 18 ak plis · Gason · Mizajou Sep 29, 2026 · NCT07569926A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Emory University Winship Cancer Institute, Atlanta
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 28, 2026 · NCT06095089Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
- Augusta University Research Institute, Augusta
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 28, 2026 · NCT06496256This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Tennessee Oncology, PLLC - Dalton, Dalton
- Tennessee Oncology, PLLC - Ringgold, Ringgold
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 24, 2026 · NCT07028853A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
- Emory Winship Cancer Institute, Atlanta
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 24, 2026 · NCT07543055Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- University Cancer and Blood Center LLC, Athens
- Emory University, Atlanta
Ap rekriteFaz 2/3
Laj 18 a 100 · Gason · Mizajou Sep 22, 2026 · NCT06780670A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Emory University School of Medicine - Winship Cancer Institute, Atlanta
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07114601A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- City of Hope Atlanta, Newnan
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 22, 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- University Cancer and Blood Center LLC, Athens
Ap rekriteFaz 3
Laj 18 a 100 · Gason · Mizajou Sep 22, 2026 · NCT06855277A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Newnan
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 18, 2026 · NCT06952803High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT05011383Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Emory University School of Medicine- Grady Campus ( Site 0103), Atlanta
- Winship Cancer Institute, Emory University ( Site 0003), Atlanta
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT06925737Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Grady Health System, Atlanta
- Emory Proton Therapy Center, Atlanta
- Emory University Hospital Midtown, Atlanta
- ak 3 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05946213Prostate Active Surveillance Study
- Emory University, Atlanta
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Gason · Mizajou Sep 2, 2026 · NCT00756665Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Emory University - Winship Cancer Institute, Atlanta
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT06582017Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Emory University, Atlanta
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Aug 21, 2026 · NCT04221542A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Emory University Hospital, Atlanta
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Aug 20, 2026 · NCT06785636A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Winship Cancer Institute, Emory University, Atlanta
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 17, 2026 · NCT06842498Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
- Emory University, Atlanta
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07288359Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- ak 4 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Jul 14, 2026 · NCT06592924An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
- Emory University Hospital, Atlanta
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Jul 14, 2026 · NCT06865768Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- University Cancer and Blood Center LLC, Athens
Ap rekriteFaz 4
Laj 18 a 100 · Gason · Mizajou Jun 4, 2026 · NCT05803941International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Morehouse School of Medicine, Atlanta
- Emory Winship Cancer Institute, Atlanta
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Gason · Mizajou May 22, 2026 · NCT03151629Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
- Emory University Hospital, Atlanta
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou May 14, 2026 · NCT05413850Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
- Georgia College & State University, Milledgeville
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Apr 1, 2026 · NCT06651359T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
- Emory University, Atlanta
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Mar 4, 2026 · NCT05586360REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
- Emory Proton Therapy Center, Atlanta
- Winship at Emory Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Feb 24, 2026 · NCT06650579Study of AZD0754 in Participants With Metastatic Prostate Cancer
- Research Site, Atlanta
Ap rekriteFaz 1/2
Laj 18 a 130 · Gason · Mizajou Feb 23, 2026 · NCT06267729Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
- Emory University Hospital/Winship Cancer Institute, Atlanta
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Feb 17, 2026 · NCT04725903Improving Health Literacy in African-American Prostate Cancer Patients
- Atlanta VA Medical Center, Atlanta
- Grady Memorial Hospital, Atlanta
- Emory University, Atlanta
- ak 1 plis
Ap rekrite
Laj 25 a 100 · Gason · Mizajou Jan 29, 2026 · NCT03322891cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- North Georgia Health System, Gainesville
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients
- Emory University, Atlanta
Ap rekriteFaz 1/2
Laj 18 a 90 · Gason · Mizajou Dec 19, 2025 · NCT06262139A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 114, Atlanta
- Research Site 139, Atlanta
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Nov 21, 2025 · NCT05914116Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.